Ester Badía

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end‐stage liver disease: Analysis of data from the Hepa‐C registry

Carlos Fernández‐Carrillo, Sabela Lens, Elba Llop et al. · Hepatology · 2017 · 101 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

Jordi Llaneras, Mar Riveiro‐Barciela, Sabela Lens et al. · Journal of Hepatology · 2019 · 100 citations · Full text

Pharmacy, Pharmacotherapy, Hepatitis Pharmacotherapy +10

Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world setting

Huascar Ramos, P. Linares, Ester Badía et al. · World Journal of Gastrointestinal Pharmacology and Therapeutics · 2017 · 25 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic <scp>HCV</scp> infection: Results from the Spanish <scp>HEPA</scp>‐C real‐world cohort

Marta Hernández‐Conde, Inmaculada Fernández, Christie Perelló et al. · Journal of Viral Hepatitis · 2018 · 19 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Are Steroids Still Useful in Immunosuppressed Patients With Inflammatory Bowel Disease? A Retrospective, Population-Based Study

Beatriz Sicilia, Lara Arias, Gadea Hontoria et al. · Frontiers in Medicine · 2021 · 13 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17